Evidence map›Paper›PMID 41786444›Full record

ArticleBMJ open respiratory research2026

Pulmonary function and airflow limitation in bronchiectasis: a case-control study of two independent cohorts.

Da Som Jeon, Young Ju Jung, Soo Han Kim, Bumhee Yang, Byoung Soo Kwon, Sang Haak Lee, Hyun-Kyung Lee, Jae Seung Lee, Yeon-Mok Oh, Sei Won Lee

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Da Som JeonDepartment of Pulmonology and Critical Care Medicine, Hanyang University Guri Hospital, Guri, Korea (the Republic of).
Young Ju JungDepartment of Health Promotion Center, University of Ulsan College of Medicine, Songpa-gu, Korea (the Republic of).
Soo Han KimDepartment of Pulmonology and Critical Care Medicine, Pusan National University Hospital, Busan, Korea (the Republic of).
Bumhee YangDepartment of Pulmonology and Critical Care Medicine, Chungbuk National University College of Medicine, Cheongju, Korea (the Republic of).
Byoung Soo KwonDepartment of Pulmonology and Critical Care Medicine, Seoul National University Bundang Hospital, Seongnam, Korea (the Republic of).ORCID http://orcid.org/0000-0002-8260-0688
Sang Haak LeeDepartment of Pulmonology and Critical Care Medicine, Eunpyeong St.Mary's Hospital, The Catholic University of Korea, Seoul, Korea (the Republic of).
Hyun-Kyung LeeDepartment of Pulmonology and Critical Care Medicine, Inje University Busan Paik Hospital, Busan, Korea (the Republic of).
Jae Seung LeeDepartment of Pulmonology and Critical Care Medicine, Asan Medical Center, University of Ulsan, Seoul, Korea (the Republic of).
Yeon-Mok OhDepartment of Pulmonology and Critical Care Medicine, Asan Medical Center, University of Ulsan, Seoul, Korea (the Republic of).ORCID http://orcid.org/0000-0003-0116-4683
Sei Won LeeDepartment of Pulmonology and Critical Care Medicine, Asan Medical Center, University of Ulsan, Seoul, Korea (the Republic of) seiwon@amc.seoul.kr.ORCID http://orcid.org/0000-0003-4814-6730

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBronchiectasis is a respiratory disease structurally characterised by irreversible airway dilatation. Functional impairments are also implicated in bronchiectasis, but the detailed changes in pulmonary function and the impact of clinical factors are yet to be examined. We analysed pulmonary function in patients with bronchiectasis based on their clinical features.

methodsTwo study cohorts-a multicentre bronchiectasis registry and health check-up examinees-were analysed. Airflow limitation was defined as forced expiratory volume in 1 s (FEV

resultsAmong 13 589 health check-up examinees, 606 (4.5%) had bronchiectasis; airflow limitation was more prevalent in those with bronchiectasis than in those without (17.3% vs 8.1%, p<0.001). Ever-smokers with bronchiectasis had the lowest FEV

conclusionsBronchiectasis is an independent risk factor for airflow limitation, and disease severity, smoking and

Indexed as

BronchiectasisLungAgedCase-Control StudiesFemaleForced Expiratory VolumeHumansMaleMiddle AgedPrevalenceRegistriesRespiratory Function TestsSeverity of Illness IndexSmokingVital CapacityBronchiectasis

Identifiers

PMID41786444
PMCPMC12970090

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.